Szczepanik M, Anderson L R, Ushio H, Ptak W, Owen M J, Hayday A C, Askenase P W
Department of Immunology, College of Medicine, Jagiellonian University, Krakow, Poland.
J Exp Med. 1996 Dec 1;184(6):2129-39. doi: 10.1084/jem.184.6.2129.
Contact sensitivity (CS) responses to reactive hapten Ag, such as picryl chloride (PCl) or oxazolone (OX), are classical examples of T cell-mediated immune responses in vivo that are clearly subject to multifaceted regulation. There is abundant evidence that downregulation of CS may be mediated by T cells exposed to high doses of Ag. This is termed high dose Ag tolerance. To clarify the T cell types that effect CS responses and mediate their downregulation, we have undertaken studies of CS in mice congenitally deficient in specific subsets of lymphocytes. The first such studies, using alpha beta T cell-deficient (TCR alpha -/-) mice, are presented here. The results clearly show that TCR alpha -/- mice cannot mount CS, implicating alpha beta T cells as the critical CS-effector cells. However, TCR alpha -/- mice can, after high dose tolerance, downregulate alpha +/+ CS-effector T cells adoptively transferred into them. By mixing ex vivo and then adoptive cell transfers in vivo, the active downregulatory cells in tolerized alpha -/- mice are shown to include gamma delta TCR+ cells that also can downregulate interferon-gamma production by the targeted CS-effector cells in vitro. Downregulation by gamma delta cells showed specificity for hapten, but was not restricted by the MHC. Together, these findings establish that gamma delta T cells cannot fulfill CS-effector functions performed by alpha beta T cells, but may fulfill an Ag-specific downregulatory role that may be directly comparable to reports of Ag-specific downregulation of IgE antibody responses by gamma delta T cells. Comparisons are likewise considered with downregulation by gamma delta T cells occurring in immune responses to pathogens, tumors, and allografts, and in systemic autoimmunity.
对反应性半抗原(如苦味酸氯[PCl]或恶唑酮[OX])的接触性超敏反应(CS)是体内T细胞介导的免疫反应的经典例子,显然受到多方面的调节。有大量证据表明,CS的下调可能由暴露于高剂量抗原的T细胞介导。这被称为高剂量抗原耐受。为了阐明影响CS反应并介导其下调的T细胞类型,我们对先天性缺乏特定淋巴细胞亚群的小鼠进行了CS研究。本文展示了首次此类研究,即使用αβT细胞缺陷(TCRα-/-)小鼠进行的研究。结果清楚地表明,TCRα-/-小鼠无法产生CS,这表明αβT细胞是关键的CS效应细胞。然而,TCRα-/-小鼠在高剂量耐受后,可以下调过继转移到它们体内的α+/ + CS效应T细胞。通过体外混合然后体内过继细胞转移,耐受的α-/-小鼠中的活性下调细胞被证明包括γδTCR +细胞,这些细胞在体外也可以下调靶向CS效应细胞的干扰素-γ产生。γδ细胞的下调表现出对半抗原的特异性,但不受主要组织相容性复合体(MHC)的限制。总之,这些发现表明γδT细胞无法履行αβT细胞执行的CS效应功能,但可能履行一种抗原特异性下调作用,这可能与γδT细胞对IgE抗体反应的抗原特异性下调的报道直接可比。同样也考虑了与γδT细胞在对病原体、肿瘤和同种异体移植物的免疫反应以及全身性自身免疫中发生的下调的比较。